Applied PharmacoDynamics Inc

🔬 Our lead program, H2E2, has: 💰 Secured $31M in non-dilutive funding to date 🧠 A mechanism of action with clinical proof-of-concept 🚀 A clear path toward IND filing and first-in-human clinical trials We’re now raising a Seed/Series A round to support: • Completion of IND-enabling assays • IND submission • First-in-human safety and proof-of-concept study If you’re passionate about neuroscience, addiction medicine, or biotech innovation, I’d love to connect — whether you’re an investor, operator, or fellow founder. 📩 oriana.zinani@apdynamicsinc.com 💬 Or feel free to DM me here on LinkedIn